| payload |
{"created_at":"2026-04-22T11:09:42.515 {"created_at":"2026-04-22T11:09:42.515872+00:00","dedupe_key":"signal_enriched:discovery_unusual_volume_delta:be076341284da0f8","evidence_event_ids":["evt_4455b716e105"],"signal_type":"discovery_unusual_volume_delta","source":"discovery_ingestor","value":{"aggregator_url":"https://www.nasdaq.com/articles/elevance-health-revises-annual-earnings-guidance","as_of":"2026-04-22T11:09:42.515872+00:00","canonical_url":"https://www.rttnews.com/3641168/elevance-health-revises-annual-earnings-guidance.aspx","enrichment":{"aggregator_url":"https://www.nasdaq.com/articles/elevance-health-revises-annual-earnings-guidance","article_chars":1131,"article_truncated":false,"blocked_reason":null,"candidate_id":"sc_2ddfedd83924f1d3","canonical_host":"rttnews.com","canonical_is_aggregator":false,"canonical_url":"https://www.rttnews.com/3641168/elevance-health-revises-annual-earnings-guidance.aspx","content_type":"text/html; charset=utf-8","enriched_at":"2026-04-22T11:12:39.368075+00:00","extraction_method":"trafilatura","fetched_description":"(RTTNews) - Elevance Health, Inc. (ELV) on Wednesday revised its annual earnings outlook.","fetched_title":"Elevance Health Revises Annual Earnings Guidance | Nasdaq","final_url":"https://www.nasdaq.com/articles/elevance-health-revises-annual-earnings-guidance","html_truncated":false,"paywall_likely":false,"publisher_domain":"rttnews.com","publisher_resolution":"canonical_url","requested_url":"https://www.nasdaq.com/articles/elevance-health-revises-annual-earnings-guidance","source_event_id":"evt_4455b716e105","source_quality":"medium","status_code":200,"version":"signal_enrichment_v2"},"fp":"e4b366612559a094","kind":"unusual_volume","published_at":"2026-04-22T10:30:38+00:00","publisher_domain":"rttnews.com","signal_understanding":{"analysis_basis":"article","claim_confidence":0.78,"dates_mentioned":["Wednesday","June 25","June 10"],"entities":[{"asset_class":"equity","name":"Elevance Health, Inc.","relevance":"high","symbol":"ELV","type":"company"},{"asset_class":"person","name":"Gail K. Boudreaux","relevance":"medium","symbol":"","type":"person"}],"event_type":"earnings","information_gaps":["This signal type is discovery_unusual_volume_delta, but the provided text contains no trading volume figures, no volume ratio vs average, and no direction (e.g., above/below average).","No explicit statement is provided about whether any volume move is confirmed by news versus unexplained.","A catalyst hypothesis for unusual volume cannot be grounded in the provided text beyond the earnings guidance revision itself (no volume data is given).","The article mentions a CMS matter but does not quantify the CMS financial impact separately from the per-share guidance."],"key_facts":["Elevance Health revised its annual earnings outlook upward on Wednesday.","CEO Gail K. Boudreaux said the raise is supported by greater visibility into the balance of the year and actions driving more consistent performance.","For fiscal 2026, Elevance Health now anticipates net income of at least $19.85 per share, including the company\u2019s estimate of the financial impact for the CMS matter.","For fiscal 2026, Elevance Health now projects annual adjusted profit of at least $26.75 per share, supported by underlying business strength, actions to reduce medical costs, and increased visibility.","Previously, for fiscal 2026, Elevance Health projected net income of at least $22.30 per share and adjusted income of at least $25.50 per share.","The board will pay a second quarter dividend of $1.72 per share on June 25 to shareholders of record as of June 10."],"numeric_claims":[{"label":"Fiscal 2026 net income (min) per share","value":"$19.85"},{"label":"Fiscal 2026 adjusted profit (min) per share","value":"$26.75"},{"label":"Prior fiscal 2026 net income (min) per share","value":"$22.30"},{"label":"Prior fiscal 2026 adjusted income (min) per share","value":"$25.50"},{"label":"Second quarter dividend per share","value":"$1.72"},{"label":"Dividend payment date","value":"June 25"},{"label":"Dividend record date","value":"June 10"}],"primary_claim":"Elevance Health raised its full-year (fiscal 2026) adjusted EPS guidance, projecting net income of at least $19.85 per share and annual adjusted profit of at least $26.75 per share.","relevance_score":0.62,"sentiment":"mixed","source_quality":"medium","summary":"Elevance Health (ELV) revised its fiscal 2026 earnings guidance upward, citing greater visibility and actions to drive more consistent performance and reduce medical costs. The article does not provide any unusual trading volume details.","topics":["earnings guidance","adjusted EPS","medical cost reduction","CMS matter","dividend"]},"source":"Nasdaq Markets","source_domain":"rttnews.com","summary":"(RTTNews) - Elevance Health, Inc. (ELV) on Wednesday revised its annual earnings outlook.","tickers":["ELV"],"title":"Elevance Health Revises Annual Earnings Guidance","url":"https://www.rttnews.com/3641168/elevance-health-revises-annual-earnings-guidance.aspx"}}... |